Transarterial Injection of 131i-Lipiodol, Compared With Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.108.060558
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Lipiodol Retention Pattern Predicts Transarterial Chemoembolization Therapeutic Effect in Hepatocellular Carcinoma

Universa Medicina
2016English

Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data

Hepatology
MedicineHepatology
2016English

Successful Treatment of Large-Size Advanced Hepatocellular Carcinoma by Transarterial Chemoembolization Followed by the Combination Therapy of Percutaneous Ethanol-Lipiodol Injection and Radiofrequency Ablation

Oncology Reports
MedicineCancer ResearchOncology
2006English

Retrospective Analysis of Transarterial Chemoembolization and Sorafenib in Chinese Patients With Unresectable and Recurrent Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

Efficacy of Radiofrequency Ablation Compared With Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma: A Comparative Survival Analysis

HPB
HepatologyGastroenterology
2016English

Yttrium-90 Radioembolization Versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Comparative Analysis

HPB
HepatologyGastroenterology
2016English

The Evolving Role of Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma

Hepatoma Research
2015English

A Case of Hepatocellular Carcinoma With Bile Duct Invasion Treated With Transarterial Chemoembolization

Journal of Liver Cancer
2014English

Dose Escalation in Radiotherapy for Incomplete Transarterial Chemoembolization of Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy